M Mousseau

Author PubWeight™ 33.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie. N Engl J Med 1998 4.93
2 Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601. Eur J Cancer 2012 1.76
3 Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy. J Clin Oncol 1997 1.67
4 Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy. J Clin Oncol 1996 1.25
5 A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma. Melanoma Res 2003 1.24
6 Rotenone inhibits the mitochondrial permeability transition-induced cell death in U937 and KB cells. J Biol Chem 2001 1.12
7 First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial). Br J Cancer 1999 0.96
8 Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patients. J Clin Oncol 2001 0.96
9 [Biliary peritonitis. (Apropos of 24 observations)]. Ann Chir 1972 0.92
10 Lipid peroxidation products, and vitamin and trace element status in patients with cancer before and after chemotherapy, including adriamycin. A preliminary study. Biol Trace Elem Res 1995 0.92
11 Effects of elevated CO(2) concentration on leaf characteristics and photosynthetic capacity of beech (Fagus sylvatica) during the growing season. Tree Physiol 1996 0.89
12 Randomised trial comparing three different schedules of infusional 5FU and raltitrexed alone as first-line therapy in metastatic colorectal cancer. Final results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 trial. Oncology 2006 0.88
13 Response of chemosensitive and chemoresistant leukemic cell lines to drug therapy: simultaneous assessment of proliferation, apoptosis, and necrosis. Cytometry 2000 0.88
14 [Teratoma of the neck. A report of one case (author's transl)]. J Chir (Paris) 1980 0.86
15 [Abdominal intercostal hernia. Report of four cases (author's transl)]. Sem Hop 1979 0.85
16 5-Hydroxymethyluracil excretion, plasma TBARS and plasma antioxidant vitamins in adriamycin-treated patients. Free Radic Biol Med 1996 0.84
17 [Randomised phase III trial of fotemustine versus fotemustine plus whole brain irradiation in cerebral metastases of melanoma]. Cancer Radiother 2003 0.84
18 Effects of permeability transition inhibition and decrease in cytochrome c content on doxorubicin toxicity in K562 cells. Oncogene 2006 0.84
19 Randomized comparison of prophylactic antidiarrheal treatment versus no prophylactic antidiarrheal treatment in patients receiving CPT-11 (irinotecan) for advanced 5-FU-resistant colorectal cancer: an open-label multicenter phase II study. Am J Clin Oncol 2000 0.83
20 [Abdominal intercostal hernia. Report of four cases (author's transl)]. Ann Chir 1978 0.82
21 Optimized fluorescent probe combinations for evaluation of proliferation and necrosis in anthracycline-treated leukaemic cell lines. Cell Prolif 1999 0.82
22 Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study. Br J Cancer 2012 0.82
23 [Early detection of leptomeningeal metastasis in patients with metastatic breast carcinoma: validation of CA 15-3 measurement in cerebrospinal fluid]. Ann Biol Clin (Paris) 2007 0.80
24 Efficacy and safety of the paclitaxel and carboplatin combination in patients with previously treated advanced ovarian carcinoma. A multicenter GINECO (Group d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens) phase II study. Ann Oncol 1998 0.80
25 The integration of anthracyclines in the treatment of advanced ovarian cancer. Int J Gynecol Cancer 2001 0.79
26 Urine 8-oxo-7,8-dihydro-2-deoxyguanosine vs. 5-(hydroxymethyl) uracil as DNA oxidation marker in adriamycin-treated patients. Free Radic Res 1998 0.79
27 Decreased folylpolyglutamate synthetase activity in tumors resistant to fluorouracil-folinic acid treatment: clinical data. Clin Cancer Res 1997 0.78
28 Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study. Semin Oncol 1997 0.78
29 Usefulness of PKHs for studying cell proliferation. C R Acad Sci III 1998 0.77
30 [The present place of sphincterotomy of the sphincter of Oddi in surgery for benign lesions of the common bile duct in adults. Study of 100 cases of sphincterotomy and review of the literature of the last ten years]. Ann Chir 1976 0.77
31 Can interleukin-2 reverse anthracyclin chemoresistance in metastatic soft tissue sarcoma patients. Results of a prospective phase II clinical trial. Eur Cytokine Netw 2001 0.77
32 PKH26 probe in the study of the proliferation of chemoresistant leukemic sublines. Anticancer Res 1999 0.76
33 Doppler waveform analysis versus segmental pressure and pulse-volume recording: assessment of occlusive disease in the lower extremity. Can J Surg 1984 0.76
34 [Permanent intubation of the cancerous esophagus. Limitations of indications]. Mem Acad Chir (Paris) 1968 0.75
35 Solid tumors of the liver. Diagnostic and therapeutic problems. Int Surg 1976 0.75
36 [Post-traumatic sequestra of the liver]. J Chir (Paris) 1976 0.75
37 [Indications for portacaval anastomoses in portal hypertension due to alcoholic cirrhosis. (Role of anatomo-pathological examination.)]. J Chir (Paris) 1975 0.75
38 [25 Childs' operations]. Mem Acad Chir (Paris) 1969 0.75
39 [Not Available]. Mem Acad Chir (Paris) 1958 0.75
40 [Early detection of recurrence of ovarian carcinoma by immunoscintigraphy]. Presse Med 1992 0.75
41 [Ischemic necrosis of the stump after subtotal gastrectomy. (Apropos of 2 cases.)]. J Chir (Paris) 1968 0.75
42 [Long term results of portal hypertension surgery for alcoholic cirrhosis (73 cases)]. Mem Acad Chir (Paris) 1969 0.75
43 [Technic of surgical biopsy of the liver]. Nouv Presse Med 1973 0.75
44 [Nephrotoxicity of high-dose melphalan]. Presse Med 1983 0.75
45 [Familial tumors of the testis. Apropos of 3 cases]. J Urol (Paris) 1987 0.75
46 [Prognostic tissue criteria of pT1-2, pN0-1, M0 cancers of the breast with a low or moderate metastatic potential]. Bull Cancer 1996 0.75
47 [Ligation of the portal vein in a case of cirrhosis complicated by pylethrombosis]. J Chir (Paris) 1965 0.75
48 [Diastasic perforations]. J Chir (Paris) 1972 0.75
49 [Stenosis in odditis]. Ann Chir 1972 0.75
50 [Chemotherapy of small-cell lung cancer by a combination of teniposide, ifosfamide and carboplatin]. Bull Cancer 1994 0.75
51 [Modulation of indications of adjuvant hormone therapy with tamoxifen in T1T2/N0N1 breast cancers. Preliminary results of a multicenter study with 695 cases]. Bull Cancer 1994 0.75
52 [Letter: Indications for portacaval anastomosis in portal hypertension caused by alcoholic cirrhosis. Role of anatomo-pathologic examination]. Nouv Presse Med 1974 0.75
53 [Emergency treatment of hemorrhages caused by rupture of esophageal varices in alcoholic cirrhosis. Role of portacaval anastomosis during the hemorrhage]. Med Chir Dig 1978 0.75
54 [Aneurysms of the digestive arteries]. Med Chir Dig 1980 0.75
55 [Clinical and surgical aspects of fibro-angio-adenomatosis]. J Chir (Paris) 1973 0.75
56 [Considerations on a series of calculous cancer of the gallbladder (author's transl)]. Ann Chir 1975 0.75
57 [Prognostic value of estradiol and progesterone receptors in stage I and II breast cancer with an adjuvant treatment]. Bull Cancer 1987 0.75
58 [Evaluation of the diagnostic usefulness of CA125 immunoscintigraphy for ovarian carcinoma follow-up after treatment: contribution of this technique in Grenoble University Medical Center]. Bull Cancer 1997 0.75
59 [Cirsoid aneurysm of the radix of the lower extremity. Exeresis and recovery]. Mem Acad Chir (Paris) 1967 0.75
60 [One-step bilateral excision of cervical lymph nodes]. J Chir (Paris) 1972 0.75
61 [Association of 5-FU, CDDP and hypofractionated radiotherapy in recurrences of subtentorial astrocytomas and malignant gliomas in adults]. Bull Cancer Radiother 1990 0.75
62 Rapidly recycled, intensive alternating chemotherapy in heavily pretreated progressive nonseminomatous germ cell tumors a feasibility study. Urol Oncol 2011 0.75
63 Coexpression of multidrug resistance involve proteins: a flow cytometric analysis. Anticancer Res 1998 0.75
64 [Primary retroperitoneal fibrosis. Apropos of 2 cases]. Mem Acad Chir (Paris) 1966 0.75
65 [Contribution of dynamic interpretation of CA 125 measurements to the understanding of an atypical clinical case]. Ann Biol Clin (Paris) 2008 0.75
66 A recent increase in the incidence of prostatic carcinoma in a French population: role of ultrasonography and prostatic specific antigen. Eur J Cancer 1995 0.75
67 [A series of 11 islet-cell tumours of the pancreas with insulin secretion (author's transl)]. Ann Chir 1976 0.75
68 [An unusual cause of dysphagia: aneurysm of the celiac trunk]. Ann Chir 1983 0.75
69 [Thrombotic microangiopathy and chronic renal failure caused by mitomycin C in 4 women treated for breast cancer]. Nouv Presse Med 1982 0.75
70 [Surgery on the irradiated breast]. J Radiol Electrol Med Nucl 1967 0.75
71 [Carcinoid tumor of the 2d duodenal segment in a 12-year-old child. Duodeno-cephalo-pancreatectomy]. Chirurgie 1973 0.75
72 [Letter: Prevention of abdominal eviscerations]. Nouv Presse Med 1975 0.75